Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Ajovy
Pharma
Teva's subdued outlook puts damper on strong 2024 results
Despite finishing strong in 2024, Teva’s cautious approach to the new year appears to have investors spooked.
Fraiser Kansteiner
Jan 29, 2025 1:13pm
Teva rides growth momentum through Q2, boosts '24 sales outlook
Jul 31, 2024 9:11am
Teva CEO celebrates progress in 'Pivot to Growth' plan
May 8, 2024 3:02pm
Teva CEO Richard Francis earns $25.7M thanks to welcome package
Apr 17, 2024 1:00pm
Teva rolls along in 2nd year of 'Pivot to Growth' strategy
Jan 31, 2024 3:06pm
Teva, Eli Lilly agree to dismiss one of Teva's patent cases
Nov 28, 2023 12:07pm
